Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MYGN Myriad Genetics > Main Composition
MYGN Myriad Genetics
19.080
-0.430-2.20%
Post Mkt Price
19.0800.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Molecular diagnostic revenues--666.4M96.50%
Pharmaceutical and clinical services revenue--24.2M3.50%
Region Unit:USD
nameYOYOperating income%
United States--603.7M87.42%
Rest of world--86.9M12.58%
Company Overview More
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
CEO: Mr. Paul J. Diaz
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...